An Early Phase 1 interventional study of Rhomboid Intercostal and Sub-Serratus block in Rhomboid Intercostal Block, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-29.
Sponsored by Cairo University · Early Phase 1, Interventional, and Diagnostic
Rhomboid intercostal block (RIB) is a new interfascial plane block describe by Elsharkawy et al. in 2016. The region described is understood because the triangle of auscultation that's bounded medially by inferior a part of the trapezius, inferiorly by the superior border of latissimus dorsi, and laterally by the medial border of the scapula. In this ultrasound-guided block, the local anaesthetic drug is run between the rhomboid major and therefore the intercostal fascia at the extent of T6-T7 and provides analgesia of T3-T8 dermatomes
Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
patients will receive sham block.
Drug: Rhomboid Intercostal and Sub-Serratus block
will receive Rhomboid Intercostal and Sub-Serratus block under ultrasound guidance
Drug: Rhomboid Intercostal and Sub-Serratus block
Rhomboid Intercostal and Sub-Serratus block under ultrasound guidance
nalbuphine consumption i
Postoperative nalbuphine consumption
Time frame: 24 hours
nalbuphine consumption.
intraoperative nalbuphine consumption.
Time frame: 2 hours
Patient's satisfaction
using 1-4 scales (1, bad; 2, moderate; 3, good; 4, excellent;
Time frame: 24 hours
Plan to share: Undecided — still working
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University